Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $447.29 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $97.57 | 7 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $67.46 | 4 | $0 (2019) |
| PFIZER INC. | $51.36 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $48.43 | 4 | $0 (2020) |
| Orexigen Therapeutics, Inc. | $38.58 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $36.18 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.62 | 1 | $0 (2020) |
| Amarin Pharma Inc. | $23.15 | 1 | $0 (2020) |
| Genentech USA, Inc. | $17.90 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $14.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $108.91 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($26.62) |
| 2019 | $111.76 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($67.46) |
| 2018 | $119.90 | 8 | Merck Sharp & Dohme Corporation ($43.05) |
| 2017 | $106.72 | 7 | SANOFI-AVENTIS U.S. LLC ($36.18) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/18/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2020 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: WOMENS HEALTH | ||||||
| 09/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Cardiovascular | ||||||
| 12/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: DIABETES | ||||||
| 11/27/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Virology & Specialty Care | ||||||
| 11/27/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: DIABETES | ||||||
| 11/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: DIABETES | ||||||
| 08/16/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: DIABETES | ||||||
| 03/12/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL9 | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: VACCINE | ||||||
| 09/25/2018 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: WOMENS HEALTH | ||||||
| 08/22/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), FLULAVAL | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: VACCINES | ||||||
| 08/06/2018 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON, GARDASIL9 | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: WOMENS HEALTH | ||||||
| 07/27/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/16/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: WOMENS HEALTH | ||||||
| 05/04/2018 | Ironwood Pharmaceuticals, Inc | DUZALLO (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Rheumatology | ||||||
| 01/27/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/12/2018 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Obesity | ||||||
| 12/15/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/01/2017 | Merck Sharp & Dohme Corporation | VYTORIN (Drug), ZETIA, ASMANEX | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: DIABETES | ||||||
| 10/06/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: OBESITY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $1,353 | $485.20 |
| 2022 | 4 | 206 | 211 | $43,561 | $18,356 |
| 2021 | 2 | 43 | 45 | $9,711 | $4,323 |
| 2020 | 1 | 19 | 19 | $2,907 | $737.52 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 11 | $1,353 | $485.20 | 35.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 83 | 83 | $24,153 | $9,679 | 40.1% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 88 | 93 | $14,590 | $6,300 | 43.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 19 | 19 | $2,850 | $1,515 | 53.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 16 | 16 | $1,968 | $861.65 | 43.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 21 | 21 | $6,111 | $2,582 | 42.2% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Facility | 2021 | 22 | 24 | $3,600 | $1,741 | 48.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 19 | $2,907 | $737.52 | 25.4% |
About Dr. Charles Pinney, M.D
Dr. Charles Pinney, M.D is a Emergency Medicine healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902819451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Pinney, M.D has received a total of $447.29 in payments from pharmaceutical and medical device companies, with $108.91 received in 2020. These payments were reported across 28 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($447.29).
As a Medicare-enrolled provider, Pinney has provided services to 279 Medicare beneficiaries, totaling 286 services with total Medicare billing of $23,902. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, General Practice
- Location Vancouver, WA
- Active Since 08/15/2006
- Last Updated 10/06/2022
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902819451
Products in Payments
- TRADJENTA (Drug) $67.46
- CHANTIX (Drug) $51.36
- FARXIGA (Drug) $48.43
- CONTRAVE (Drug) $38.58
- TOUJEO (Drug) $36.18
- NUVARING (Drug) $31.44
- NEXPLANON (Drug) $28.64
- VYVANSE (Drug) $26.62
- Vascepa (Drug) $23.15
- Xofluza (Drug) $17.90
- BEXSERO (Biological) $14.45
- PNEUMOVAX 23 (Biological) $14.18
- XARELTO (Drug) $13.79
- VYTORIN (Drug) $12.23
- DUZALLO (Drug) $11.80
- ASMANEX (Drug) $11.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Vancouver
Peter Mullins
Emergency Medicine — Payments: $3,990
Christopher Finley, Md, MD
Emergency Medicine — Payments: $1,626
Arnold Cha, M.d, M.D
Emergency Medicine — Payments: $1,127
Daniel Bissell, Md, MD
Emergency Medicine — Payments: $360.63
Armida Nunez, Md, MD
Emergency Medicine — Payments: $237.09
Dr. Mark Foster, Md, MD
Emergency Medicine — Payments: $190.50